A Real-world Study of the Effectiveness of Angiotensin Receptor-Neprilysin Inhibitor Therapy in Hypertensive Patients in the United Arab Emirates
Clinical trial NCT07465666 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07465666
- Sponsor
- Novartis Pharmaceuticals
- Status
- NOT_YET_RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2026-08-15
- Primary completion
- 2027-08-15
- Enrollment
- 500
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.